Titan Medical Inc.(Us) (TSE:TMD) has released an update.
Titan Medical Inc. has reported a significant fiscal year with revenue reaching $17.6 million, a stark increase from the previous year’s nil, largely due to licensing agreements with Medtronic and Intuitive. The company’s financial health has improved with cash on hand tripling and a positive shift in working capital. Additionally, Titan Medical is preparing for a strategic all-stock merger with Conavi Medical Inc., pending shareholder and regulatory approval.
For further insights into TSE:TMD stock, check out TipRanks’ Stock Analysis page.
